Thiogenesis Therapeutics Corp TTIPF:OTCPK

RT Quote | Exchange | USD
Last | undefined
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-

Key Stats

  • Market Cap13.49M
  • Shares Out28.24M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap13.49M
  • Shares Out28.24M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Thiogenesis Therapeutics Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Thiogenesis Therapeutics, Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is principally focused on drug development, regulatory approvals and commercialization in North America and Europe. It is engaged in developing sulfur containing compounds that have the potential as therapeutics to treat a number of life-threatening diseases. The Company has patented and synthesized three compounds that are precursors to the sulfur containing compound...
Christopher Starr Ph.D.
Independent Chairman of the Board
Patrice Rioux M.D., Ph.D.
Chief Executive Officer, Director
Brook Riggins
Chief Financial Officer, Director
Address
4 King Street West, Suite 401
Toronto, ON
M5H 1B6
Canada